Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment

NCT07264413 is registered in ClinicalTrials.gov with Cardiovascular and Interventional Radiological Society of Europe as lead sponsor.

NCT NCT07264413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07264413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment
Lead sponsor
Cardiovascular and Interventional Radiological Society of Europe
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
December 31, 2030
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoid, hemorrhoid bleeding